Summit Therapeutics Inc. (SMMT)
Summit Therapeutics Inc. ROIC - WACC
| Jan'05 | Jan'06 | Jan'07 | Jan'08 | Jan'09 | Jan'10 | Jan'11 | Jan'12 | Jan'13 | Jan'14 | Jan'15 | Jan'16 | Jan'17 | Jan'18 | Jan'19 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROIC - WACC | (17,407.5%) | (400.8%) | (177.7%) | (91.7%) | (65.4%) | (89.4%) | (167.7%) | (286.8%) | (1,043.7%) | (350.8%) | (317.0%) | (381.7%) | (428.7%) | (96.8%) | 82.4% | (314.5%) | (518.1%) | (618.6%) | (46.9%) | (63.4%) |
Summit Therapeutics Inc. (SMMT) ROIC - WACC comparison analysis
SMMT key stats
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
investors
worldwide
FAQ
1) What is Summit Therapeutics Inc.'s ROIC - WACC?
As of today, Microsoft Corp's last 12-month ROIC - WACC is (2,483.9%), based on the financial report for Sep 30, 2024 (Q3 2024). The average annual ROIC - WACC for Summit Therapeutics Inc. have been (1,593.9%) over the past three years, and (1,292.1%) over the past five years.
2) Is Summit Therapeutics Inc.'s ROIC - WACC Good?
As of today, Summit Therapeutics Inc.'s ROIC - WACC is (2,483.9%), which is lower than industry median of (132.6%). It indicates that Summit Therapeutics Inc.'s ROIC - WACC is Bad.